APOLLOHOSP8,894.00

Apollo Hospitals Enterprise Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersFORTISMAXHEALTHMEDANTASUNPHARMACIPLADRREDDYDIVISLABTORNTPHARMMcap ₹1.28L Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations19,059.221,794.025,228.526,429.9
Other Income106.3200.3191.6200.2
Total Income19,165.521,994.325,420.126,630.1
Expenses
+ Cost of Materials Consumed2,454.12,754.43,040.83,129.7
+ Purchases of Stock-in-Trade7,384.98,556.710,056.410,508.7
+ Changes in Inventories-33.5-1.1-21.6-13.3
+ Employee Benefit Expense2,493.72,769.23,000.33,083.5
+ Finance Costs449.4458.5449.6461.7
+ Depreciation & Amortisation687.0757.5876.1896.5
+ Other Expenses4,369.34,693.05,383.35,711.8
Total Expenses17,804.919,988.222,784.923,778.6
EBITDA2,390.73,021.83,769.34,009.5
EBIT1,703.72,264.32,893.23,113.0
Profit
PBT before Exceptional Items1,360.62,006.12,635.22,851.5
+ Exceptional Items1.90.0-19.2-19.2
Pretax Income1,362.52,006.12,616.02,832.3
+ Current Tax436.8526.3629.3714.8
+ Deferred Tax8.77.728.9-9.8
Tax Expense445.5534.0658.2705.0
+ Share of Associates & JVs18.033.044.944.7
Net Income935.01,505.12,002.72,172.0
+ Net Income — Continuing Ops917.01,472.11,957.82,127.3
+ Other Comprehensive Income-10.4-6.358.456.4
Total Comprehensive Income924.61,498.82,061.12,228.4
Net Income to Common898.61,445.91,941.72,089.5
Minority Interest36.459.261.082.5
Per Share
Basic EPS62.50100.56135.04145.34
Diluted EPS62.50100.56134.94145.26
Other Comprehensive Income — detail
+ Other Comprehensive Income-6.358.456.4
+ Items NOT to be Reclassified to P&L-14.2-8.661.959.8
+ Tax on Items NOT to be Reclassified-3.6-1.76.46.4
+ Tax on Items NOT to be Reclassified — alt tag-3.6
+ Items to be Reclassified to P&L0.20.62.93.0
Comprehensive Income — Owners of Parent-10.21,440.91,999.42,145.2
Comprehensive Income — Non-controlling Interests-0.257.961.783.2
Per Share — as-filed variants
Basic EPS — Continuing Operations62.50100.56135.04145.34
Diluted EPS — Continuing Operations62.50100.56134.94145.26
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit9,253.710,484.012,152.912,804.8
Gross Margin %48.5548.1048.1748.45
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)1,360.62,006.12,635.22,851.5
− Exceptional Items (reconciliation)1.90.0-19.2-19.2
Net Income Adj (tax-effected)933.71,505.12,017.12,186.4
EPS Adj62.41100.56136.01146.30
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value5.0010.005.005.00
Paid Up Equity Capital71.971.971.971.9
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 146%.